BOSTON (AP) — BOSTON (AP) — Zevra Therapeutics, Inc. (ZVRA) on Wednesday reported second-quarter earnings of $8.8 million.
The Boston-based company said it had net income of 14 cents per share. Earnings, adjusted for non-recurring costs, were 25 cents per share.
The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 8 cents per share.
The specialty pharmaceutical company posted revenue of $39.7 million in the period, which also beat Street forecasts. Three analysts surveyed by Zacks expected $32.3 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ZVRA at https://www.zacks.com/ap/ZVRA
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
